Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disord... Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin. 더 보기
VANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) announces that further to its news...
NEW YORK AND VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (Bright Minds or the Company) (NASDAQ: DRUG), a biotechnology company focused on...
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -7.155 | -14.1683168317 | 50.5 | 58 | 41.6401 | 348357 | 50.66481582 | CS |
4 | 40.725 | 1554.38931298 | 2.62 | 79.02 | 2.47 | 8304351 | 40.04607919 | CS |
12 | 42.335 | 4191.58415842 | 1.01 | 79.02 | 0.94 | 3270734 | 34.7788391 | CS |
26 | 42.305 | 4067.78846154 | 1.04 | 79.02 | 0.9305 | 1543114 | 34.5263507 | CS |
52 | 42.115 | 3423.98373984 | 1.23 | 79.02 | 0.93 | 791872 | 33.93816625 | CS |
156 | 8.345 | 23.8428571429 | 35 | 79.02 | 0.93 | 1486498 | 14.54506084 | CS |
260 | -1.405 | -3.13966480447 | 44.75 | 79.02 | 0.93 | 1478960 | 14.5502597 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관